Sleep apnea and weight loss medications
Sleep apnea and weight loss medications
How obesity treatment and weight-loss medications fit into comprehensive obstructive sleep apnea care.
Overview
Weight reduction can improve OSA in many patients with obesity. Zepbound has an FDA-approved indication for moderate-to-severe OSA in certain adults with obesity, but medication does not replace diagnostic testing, PAP assessment or follow-up sleep evaluation.
Key points
Confirm diagnosis
Treatment begins with an objective sleep study and clinical assessment.
Treat both conditions
PAP controls airway obstruction while weight treatment addresses an important contributor.
Medication choice
Eligibility, contraindications, side effects and coverage must be reviewed.
Reassess
Repeat testing may be considered after substantial loss before changing PAP.
How W8MD can help
W8MD offers sleep testing, PAP management and physician-supervised obesity treatment in one coordinated program.
Frequently asked questions
Can I stop CPAP after starting medication?
No; continue prescribed PAP until the sleep clinician reassesses you.
Is Zepbound approved for mild OSA?
The FDA OSA indication is for moderate-to-severe OSA in adults with obesity.
Will insurance cover it?
Coverage varies and may require prior authorization.
Evidence and authoritative sources
Contact W8MD
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised care in Brooklyn, New York and Northeast Philadelphia. Telehealth may be available for eligible patients based on location and applicable requirements.
Contact W8MD
